Rajesh Rajpal, MD, chief medical officer, global head of clinical medical affairs, Johnson & Johnson Vision, discusses how greater visual needs are contributing to adverse eye health in younger populations.
With visual needs rising substantially in recent years, eye conditions such as cataract have been shown to be more impactful at an earlier age, said Raj Rajpal, MD, chief medical officer, global head of clinical medical affairs, Johnson & Johnson Vision.
Transcript
Can you speak on the growing prevalence of cataracts in younger populations?
I wouldn't say that they're necessarily being noticed at an earlier age, I think it's just more impactful at an earlier age because of our visual needs. So, certainly all of the types of conditions we've talked about that can contribute to cataracts at an earlier age, we still need to watch for.
Again, whether they're medical causes, trauma, or medications as examples, but because of our greater visual needs, we are finding that we're doing cataract surgery at an earlier age because patients’ vision is impacting their life and that's when we primarily choose to perform cataract surgery.
It’s when a patient's vision is impacting their daily functioning, and therefore then we can, by cataract surgery, remove the natural lens, the cloudy lens of the eye, and implant an intraocular lens that makes up for the power. And then we have different options in how we select those intraocular lenses and what we do in cataract surgery.
NGS-Based Test Accurately Detects Post–Allo-HSCT Relapse in AML, MDS
February 21st 2025The next-generation sequencing (NGS)–based AlloHeme test accurately predicted relapse following allogeneic hematopoietic stem cell transplantation (allo-HSCT) in acute myeloid leukemia (AML) and myelodysplastic syndromes (MDS).
Read More
Insurance Payer Is Associated With Length of Stay After Traumatic Brain Injury
February 21st 2025Among hospitalized patients with traumatic brain injury, Medicaid fee-for-service was associated with longer hospital stays than private insurance and Medicaid managed care organizations.
Read More
Politics vs Science: The Future of US Public Health
February 4th 2025On this episode of Managed Care Cast, we speak with Perry N. Halkitis, PhD, MS, MPH, dean of the Rutgers School of Public Health, on the public health implications of the US withdrawal from the World Health Organization and the role of public health leaders in advocating for science and health.
Listen
NSCLC Advancements Offer Hope, but Disparities Persist
February 20th 2025Ioana Bonta, MD, Georgia Cancer Specialists, discusses the evolving state of non-small cell lung cancer (NSCLC) treatments, their impact on patient outcomes, and the need to address ongoing disparities in these populations.
Read More
Abortion in 2025: Access, Fertility, and Infant Mortality Updates
February 20th 2025While Republican state-led efforts aim to increase restrictions to abortion care and access to mifepristone and misoprostol in 2025, JAMA authors join the conversation with their published research and commentary.
Read More